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ABSTRACT
The order Nidovirales currently comprises four virus families: Arteriviridae, Coronaviridae (divided into the subfamilies Coro-
navirinae and Torovirinae), Roniviridae, and the recently recognized Mesoniviridae. RNA cap formation and methylation have
been best studied for coronaviruses, with emphasis on the identification and characterization of two virus-encoded methyltrans-
ferases (MTases) involved in RNA capping, a guanine-N7-MTase and a ribose-2=-O-MTase. Although bioinformatics analyses
suggest that these MTases may also be encoded by other nidoviruses with large genomes, such as toroviruses and roniviruses, no
experimental evidence has been reported thus far. In this study, we show that a ronivirus, gill-associated virus (GAV), encodes
the 2=-O-MTase activity, although we could not detect 2=-O-MTase activity for the homologous protein of a torovirus, equine
torovirus, which is more closely related to coronaviruses. Like the coronavirus 2=-O-MTase, the roniviral 2=-O-MTase harbors a
catalytic K-D-K-E tetrad that is conserved among 2=-O-MTases and can target only the N7-methylated cap structure of adeny-
late-primed RNA substrates. However, in contrast with the coronavirus protein, roniviral 2=-O-MTase does not require a protein
cofactor for stimulation of its activity and differs in its preference for several biochemical parameters, such as reaction tempera-
ture and pH. Furthermore, the ronivirus 2=-O-MTase can be targeted by MTase inhibitors. These results extend our current un-
derstanding of nidovirus RNA cap formation and methylation beyond the coronavirus family.
IMPORTANCE
Methylation of the 5=-cap structure of viral RNAs plays important roles in genome replication and evasion of innate recognition
of viral RNAs by cellular sensors. It is known that coronavirus nsp14 acts as an N7-(guanine)-methyltransferase (MTase) and
nsp16 as a 2=-O-MTase, which are involved in the modification of RNA cap structure. However, these enzymatic activities have
not been shown for any other nidoviruses beyond coronaviruses in the order Nidovirales. In this study, we identified a 2=-O-
methyltransferase encoded by ronivirus that shows common and unique features in comparison with that of coronaviruses.
Ronivirus 2=-O-MTase does not need a protein cofactor for MTase activity, whereas coronavirus nsp16 needs the stimulating
factor nsp10 for its full activity. The conserved K-D-K-E catalytic tetrad is identified in ronivirus 2=-O-MTase. These results ex-
tend our understanding of nidovirus RNA capping and methylation beyond coronaviruses and also strengthen the evolutionary
and functional links between roniviruses and coronaviruses.
A5=-terminal cap structure, an N7-methylguanosine linked tothe first templated nucleotide via a 5=-5= triphosphate bridge,
is employed widely in viral and eukaryotic cellular mRNAs and
plays a critical role in mRNA stability and translation (1–3). The
basic cap-0 structure m7GpppN is formed by sequential reactions
catalyzed by an RNA triphosphatase, a guanylyltransferase, and a
guanine-N7-methyltransferase (N7-MTase) (1, 2, 4). In higher
eukaryotes and most viruses, the cap-0 structure is further meth-
ylated at the ribose 2=-O position of the first nucleotide by ribose
2=-O-methyltransferase (2=-O-MTase) to form a cap-1 structure
(m7GpppNm2) (4–6). Recently, it has been reported that 2=-O
methylation of the cap of viral mRNAs is important for RNA
viruses to evade host innate immune responses by preventing the
recognition of their mRNAs as “nonself” (7, 8). Therefore, viral
2=-MTase represents a potential target for antiviral drug develop-
ment. Generation of 2=-O-MTase-deficient viruses has been used
as a strategy to develop effective live attenuated vaccines (9–12).
Chemical and polypeptide inhibitors targeting viral 2=-O-MTase
have been shown to function as antivirals (13–15).
The order Nidovirales includes the most complex positive-
sense single-stranded RNA (ssRNA) viruses with human and an-
imal hosts, including the highly pathogenic severe acute respira-
tory syndrome coronavirus (SARS-CoV) and Middle East
respiratory syndrome coronavirus (MERS-CoV). It currently
consists of four virus families, Arteriviridae (12.7- to 15.7-kb ge-
nomes; known as small-genome nidoviruses), Coronaviridae,
Roniviridae, and the recently recognized Mesoniviridae (26.3 to
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31.7 kb) (the last three families are referred to as large-genome
nidoviruses) (16). The family Coronaviridae is further divided into
two subfamilies, Coronavirinae (for coronaviruses) and Toroviri-
nae (for toroviruses). Nidovirus replicative enzymes are evolu-
tionarily related, and the viruses share several common features,
like the synthesis of a set of subgenomic mRNAs from subge-
nome-length negative-stranded templates and the acquisition of
various RNA-processing enzymes that play roles in virus replica-
tion (17). In the past decade, cap formation and methylation in
coronaviruses have been extensively studied, focusing on two vi-
rus-encoded S-adenosyl-L-methionine (SAM, or AdoMet)-de-
pendent MTases: an N7-MTase and a 2=-O-MTase. Our previous
work has demonstrated that one of the functions of coronavirus
nonstructural protein 14 (nsp14) is to act as an N7-MTase (18,
19), while other studies have shown that coronavirus nsp16 acts as
a 2=-O-MTase (20). In the case of SARS-CoV, that role requires
the viral cofactor nsp10, although feline coronavirus (FCoV)
nsp16 also displayed activity in the absence of nsp10 (5, 15, 20–
22). However, there is no experimental evidence to show that any
other nidoviruses (except coronaviruses) possess a functional
methyltransferase.
Gill-associated virus (GAV) is the type species of the genus
Okavirus in the family Roniviridae of the order Nidovirales and has
been associated with mortalities in black tiger shrimps (Penaeus
monodon) and economic losses to shrimp farming in eastern Aus-
tralia (23, 24). GAV (genotype 2) is one of six known genotypes in
the yellow head complex of nidoviruses, which also contains yel-
low head virus (YHV) (genotype 1) and four other genotypes (25).
GAV and YHV are morphologically indistinguishable, and they
are both highly pathogenic for P. monodon (26, 27). GAV, as well
as the other five genotypes, is an enveloped, rod-shaped, positive-
sense ssRNA virus with a genome of about 26 kb (23, 25, 28). In
common with other nidoviruses, the 5=-terminal 20 kb of the GAV
genome includes two long, overlapping open reading frames
(ORFs) and is translated into two large polyproteins, pp1a and
pp1ab, via a 1 ribosomal frameshift (29). ORF1a encodes a pu-
tative papain-like protease and a putative 3C-like protease that
bridge the gap between the distantly related chymotrypsin-like
cysteine proteinases of coronaviruses and potyviruses (30, 31). It
was predicted that pp1ab contains a putative helicase (HEL) do-
main, RNA-dependent RNA polymerase (RdRp) synthesis, an ex-
onuclease (Exon) domain, and an MTase domain in an order
similar to that of other nidoviruses (17, 29), suggesting that GAV
shares a common ancestor with the other members of the nidovi-
ruses. GAV and the closely related YHV appear to be the first
nidoviruses isolated from an invertebrate, and as marine inverte-
brates are prior to vertebrates in evolution, GAV may be a relic of
the ancient nidovirus (29). The newly identified alphamesonivirus
1, which belongs to the Mesoniviridae and also infects invertebrate
hosts, has phylogenetic relationship to the Coronaviridae, and
phylogenetic analysis has shown that nidoviruses may have
evolved from arthropods (32, 33).
According to bioinformatics analysis, all nidoviruses except
arteriviruses encode a 2=-O-MTase domain at the C-terminal end
of their large pp1ab replicase polyprotein, whereas all large-ge-
nome nidoviruses except toroviruses possess an N7-MTase do-
main following their exoribonuclease domain (17, 32, 34). We
have attempted to address whether the large-genome noncorona-
viral nidoviruses also encode methyltransferases involved in viral
RNA cap methylation by utilizing the genetic and biochemical
methodologies established in our laboratory (5, 18), but we failed
to detect N7-MTase activity for any of the proteins encoded by
roniviruses, mesoniviruses, and toroviruses (unpublished re-
sults). In this study, we show that the MTase domain of a ronivirus
(GAV) (arbitrarily named “nsp16” by analogy with the location
and function of its coronavirus homolog), but not the corre-
sponding torovirus domain (also named nsp16), possesses 2=-O-
MTase activity in vitro. We further demonstrate that ronivirus
nsp16 alone can efficiently execute its MTase activity, which is in
contrast with coronavirus nsp16, which requires virus-encoded
nsp10 as a cofactor for its full function (15). These results extend
our understanding of nidovirus RNA capping and methylation
and strengthen the evolutionary and functional links between
roniviruses and coronaviruses.
MATERIALS AND METHODS
Radioactive reagents. S-Adenosyl[methyl-3H]methionine (67.3 Ci/
mmol; 0.5 Ci/l) and [-32P]GTP (3,000 Ci/mmol; 10 mCi/ml) were
purchased from PerkinElmer.
Cloning, expression, and protein purification. The genomic cDNA
of shrimp GAV, the type species of the Roniviridae, was kindly provided by
J. A. Cowley and was used as the template to construct the expression
constructs. Two pairs of PCR primers were used to amplify the gene frag-
ments of GAV: 5=-CGGGATCCCTCAGTTACTCAGGCACCGC-3=
(sense) and 5=-CCCTCGAGCTCGTGCTTGACTGGGATGG-3= (anti-
sense) for GAV nsp10 and 5=-CGGGATCCCTCTACCACGTCGCTCCT
AC-3= (sense) and 5=-CCCTCGAGAAATTTGATGAATCTGGGAG-3=
(antisense) for GAV nsp16, which correspond to nucleotides 11703 to
12212 and 19403 to 20089 of the GAV genome (GI|166851932), respec-
tively. These PCR products were cloned into the Escherichia coli expres-
sion vector pGEX-6p-1, resulting in the expression constructs pGEX-6p-
1-GAV nsp10 and pGEX-6p-1-GAV nsp16. The mutant plasmids of GAV
nsp16 were generated by one-step PCR with mutagenic primers.
E. coli BL21(DE3), transformed with pGEX-6p-1-GAV nsp10 or
nsp16, was grown in Luria broth (LB) medium containing ampicillin at
37°C. When the optical density at 600 nm (OD600) of the culture reached
0.6, isopropyl--D-thiogalactopyranoside (IPTG) was added to a final
concentration of 0.4 mM and induced at 16°C for 16 h. Bacterial cells were
harvested by centrifugation and lysed by sonication. Glutathione S-trans-
ferase (GST)-tagged fusion proteins were purified from the cell lysate by
affinity chromatography using glutathione resin (GenScript) according to
the manufacturer’s instructions. GAV nsp10 (pp1a residues 3879 to 4048;
170 amino acids [aa]) fused with an N-terminal GST tag is about 45 kDa,
which was confirmed by SDS-PAGE. GAV nsp16 (pp1ab residues 6446 to
6673; 228 aa) carrying an N-terminal GST tag was about 52 kDa.
The genes of equine torovirus (EToV) were obtained by PCRs with the
template of EToV genome cDNA (GI|190360102), kindly provided by
Eric J. Snijder. We performed bioinformatics analysis to predict the pro-
teinase cleavage sites and arbitrarily named the most C-terminal cleavage
product of pp1b EToV nsp16 (the predicted 2=-MTase domain) and
named the putative cleavage product that is upstream of the 2=,5=-phos-
phodiesterase domain of pp1a EToV nsp10. The following primers were
used to amplify the gene fragments: sense, 5=-CGGGATCCGGTGTTAG
ATTGGGAGGTGT-3=, and antisense, 5=-CCCTCGAGCTGAGGCTTAA
AAACTGGA-3= for EToV nsp10 (nucleotides [nt] 13560 to 14018
of the genome) and 5=-CGGGATCCAAGGATTTTGTAAGGTCGTA-3=
(sense) and 5=-CCCTCGAGATGTTCCATTTGGCACAAC-3= (anti-
sense) for EToV nsp16 (nt 20597 to 21391). The PCR fragments were
cloned into E. coli expression vectors pET30a and pGEX-6p-1, respec-
tively, generating the plasmids pET30a-EToV nsp10 and pGEX-6p-1-
EToV nsp16.
The GST fusion protein EToV nsp16 (pp1ab residues 6593 to 6857;
265 aa) was expressed and purified similarly to GAV nsp16, and the fusion
protein size was 57 kDa. pET30a-EToV nsp10 was transformed into E. coli
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BL21(DE3), and the cells were grown in LB medium containing kanamy-
cin at 37°C. When the OD600 of the culture reached 0.6, IPTG was added
to a final concentration of 0.4 mM, and the culture was grown for an
additional 16 h at 16°C. The bacterial cells were harvested by centrifuga-
tion and lysed by sonication. The C-terminally 6-histidine-tagged protein
EToV nsp10 was purified from the cell lysate by affinity chromatography
using Ni-nitrilotriacetic acid (NTA) according to the manufacturer’s in-
structions (Qiagen). EToV nsp10 (pp1a residues 4247 to 4399; 153 aa) was
17 kDa in size. The predicted sizes of these two proteins were in accor-
dance with their sizes in SDS-PAGE analysis.
SARS-CoV nsp10 and nsp16 were expressed and purified as described
in our previous work (5).
Preparation of RNA substrates. An RNA corresponding to the 68-nt
5=-untranslated region (UTR) of GAV was transcribed in vitro using the
PCR products as a template, and the template was amplified from GAV
cDNA (the primers were as follows: 5=-CAGTAATACGACTCACTATTA
CGTTACGTTCCACGTAC-3= and 5=-GGTCGGAAACGCTGGAAAAC-
3=). Since the first nucleotide of the GAV genome is an adenine, we used a
bacteriophage T7 2.5 promoter to direct the synthesis of an RNA tran-
script starting with an adenine. A MEGAscript kit (Life Technologies) was
used to transcribe RNA in vitro with 100 ng of PCR template in a 20-l
reaction volume. The reaction mixture was mixed thoroughly and incu-
bated for 16 h at 37°C. After the reaction, 2 units of Turbo DNase was
added, followed by a further incubation for 15 min at 37°C. For purifica-
tion of RNA, the transcription reaction mixture was extracted with phe-
nol-chloroform-isoamyl alcohol, precipitated with 75% ethanol contain-
ing sodium acetate, resuspended in RNA-free water (TianGen), and
quantitated with a Nanodrop 2000c (Thermo Scientific). The nonviral
RNA substrates pppACn, pppUC20, pppGC20, and pppCC20 were tran-
scribed and purified as described previously (5).
Capped RNAs (GpppRNA and 7MeGpppRNA) were produced using
the Vaccinia Capping System (New England BioLabs), purified through
Sephadex G-25 quick-spin columns (Roche), extracted with phenol-chlo-
roform-isoamyl alcohol, and precipitated with ethanol. 32P-labeled RNA
substrates (G*pppRNA and 7MeG*pppRNA; the asterisks indicate that the
phosphates that follow were 32P labeled) used for thin-layer chromatog-
raphy (TLC) were synthesized as described previously (18).
Biochemical assay for methyltransferase activity. The 32P-labeled
2=-O-MTase assay was performed in an 8.5-l reaction system (contain-
ing 50 mM Tris-HCl [pH 8.0], 2 mM dithiothreitol [DTT], 2 mM MgCl2,
10 units RNase inhibitor, 2  103 cpm of 7MeG*pppA-RNA, 0.2 mM SAM,
and 0.5 g of purified proteins or mutant proteins) at 20°C for 1 h. The
control substrates G*pppA-RNA and 7MeG*pppA-RNA were prepared
using the vaccinia virus protein D1-D12, which has the activities of both
GTase and N7-MTase, by incubating them at 37°C for 1 h and were pu-
rified as described previously (5). Control 7MeG*pppAm-RNA was pro-
duced by incubation of 7MeG*pppA-RNA with the vaccinia virus 2=-O-
methyltransferase VP39 (Epicentre) at 37°C. The radiolabeled capped
RNAs were digested with nuclease P1 (U.S. Biological) to release the cap
structures and were then loaded onto polyethyleneimine cellulose F plates
(Merck) for TLC analysis and developed in 0.65 M LiCl. The formation of
the 32P-labeled cap structure was determined by scanning the chromato-
gram with a phosphorimager as described previously (5, 18).
The 3H-methyl incorporation MTase activity assays were performed
in a 20-l reaction system (containing 50 mM Tris-HCl [pH 8.0], 2 mM
DTT, 2 mM MgCl2, 40 units of RNase inhibitor, 0.01 mM SAM, 0.5 Ci of
S-adenosyl[methyl-3H]methionine [67.3 Ci/mmol; 0.5 Ci/l], 1 g
proteins, and 3 g of 7MeGpppRNA substrates) at 37°C for 1 h. The 3H-
labeled products were isolated using DEAE-Sephadex A-50 columns and
quantitated by liquid scintillation counting (PerkinElmer) as described
previously (5, 35).
Multiple-sequence alignment and homology modeling. The align-
ment of the nsp16 protein sequences from different Nidovirales species
was performed by using ClustalX, and the result was imported into
ESPript 3.0, together with the three-dimensional (3D) structure of
SARS-CoV nsp16/nsp10 (Protein Data Bank [PDB] accession no. 3R24)
to assign the secondary structure. The predicted 3D structure of GAV
nsp16 was generated using the SARS-CoV nsp16 template (PDB 3R24,
chain A). The multiple-sequence alignment was done with ClustalX and
then uploaded to SWISS-MODEL for structural modeling, which was
further analyzed by PyMol.
RESULTS
Ronivirus nsp16 possesses SAM-dependent 2=-O-MTase activ-
ity in the absence of another protein cofactor. Bioinformatics
analysis revealed that all large nidoviruses encode a putative 2=-O-
MTase domain located at the most C-terminal end of the replicase
pp1ab polyprotein (17). As coronaviral nsp16, with nsp10 as a
cofactor for full activity, has been demonstrated to be a functional
2=-O-MTase (5, 15, 21, 22), we further tested the homologous
proteins of toroviruses and roniviruses for 2=-O-MTase activity.
For this purpose, we selected two representative viruses, EToV
(36), which belongs to the subfamily Torovirinae of the Corona-
viridae and is more closely related to coronaviruses, and GAV (24,
29), which belongs to the Roniviridae and is much more distantly
related to coronaviruses. As the proteinase cleavage sites are not
completely established for the large polyprotein 1ab of these two
viruses (30, 36), their protein counterparts for coronavirus nsp16
and nsp10 are arbitrarily named EToV or GAV nsp16 and nsp10,
respectively, in analogy to CoV protein nomenclature. The well-
characterized 2=-O-MTases SARS-CoV nsp10/nsp16 and vaccinia
virus VP39 were used as controls (5, 15). The locations of the
predicted proteinase cleavage sites and the nsp10 and nsp16 ho-
mologs in the pp1ab polyprotein of EToV and GAV are indicated
in Fig. 1A. It is notable that FCoV nsp16 can exert low activity of
2=-O-MTase in the absence of nsp10 (20); however, our group has
conducted an extensive analysis of the stimulating activities of
nsp10 proteins of different coronaviruses, and we showed that the
MTase activity of FCoV nsp16 can also be markedly enhanced in
the presence of nsp10 (15), indicating that the stimulating activity
of nsp10 is universal to all the coronaviruses, including FCoV.
As shown in Fig. 1B, recombinant nsp10 and nsp16 of EToV,
GAV, and SARS-CoV could be abundantly expressed in E. coli
cells and purified to more than 95% homogeneity by affinity chro-
matography.
To test the predicted 2=-O-MTase activities of these viral pro-
teins, we first conducted 2=-O-MTase activity assays in vitro using
a 21-nt RNA substrate (the cap-0 7MeGpppAC20) that was capped
and methylated at the N7 position of the cap. Transfer of the
3H-labeled methyl group from SAM to cap-0 RNA substrates
should result in cap-1 RNA (7MeGpppAmC20), which can be mea-
sured quantitatively by liquid scintillation detection. As the natu-
ral hosts of GAV are shrimps (P. monodon), which naturally have
a lower body temperature than mammals, all assays with GAV
proteins were performed at 20°C while all the other assays were at
37°C. As shown in Fig. 1C, GAV nsp16, in either the presence or
absence of GAV nsp10, showed remarkable 2=-O-MTase activity,
similar to that of vaccinia virus VP39 and SARS-CoV nsp10/
nsp16, whereas EToV nsp16 alone or in combination with nsp10
did not display any 2=-O-MTase activity, similar to the negative
control (SARS-CoV nsp10 alone). These results indicate that GAV
nsp16 alone possesses 2=-O-MTase activity, which is different
from coronavirus nsp16, which requires nsp10 as a stimulating
cofactor.
We further tested the 2=-O-MTase activity of GAV nsp16 with
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capped RNA substrates representing the 5=-terminal 68 nt of the
viral genome (7MeG*pppA-RNA, where the asterisk indicates that
the phosphate that follows was 32P labeled). GAV nsp16 was incu-
bated with 7MeG*pppA-RNA in the presence of 0.2 mM SAM.
After incubation, the RNA was digested with nuclease P1 to
release the cap structure and analyzed on TLC plates (Fig. 2A,
lane 1). The radiolabeled cap analogs G*pppA, 7MeG*pppA,
and7MeG*pppAm, generated by vaccinia virus D1/D12 and VP39,
were used as controls (Fig. 2A, lanes 2, 3, and 4). When the 2=-O
position of the first nucleotide of the substrates was methylated,
the released cap structure was 7MeG*pppAm, and the 2=-O-meth-
ylated and unmethylated cap structures could be readily sepa-
rated on TLC plates. As shown in Fig. 2A, the 2=-O-methylated
cap (7MeG*pppAm) (Fig. 2A, lane 4) generated by VP39 mi-
grated more slowly than a cap-0 structure lacking 2=-O methyl-
ation (7MeG*pppA) (Fig. 2A, lane 3), which was used as a reference
for the reaction products of GAV nsp16. The migration of the cap
structure released from 7MeG*pppA-RNA treated with GAV
nsp16 corresponded to that of 7MeG*pppAm, further confirming
that GAV nsp16 functions as a methyltransferase that adds a
methyl group in the ribose 2=-O position.
GAV nsp16 specifically methylates the N7-methylated cap-0
structure of RNA substrates with a 5=-terminal A. Next, we ex-
plored whether GAV nsp16 could methylate capped RNA Gppp-
ACn that was not methylated at the N7 position. As shown in Fig.
2B, when the uncapped RNA oligonucleotide pppAC20 and the
capped RNA oligonucleotide GpppAC20 (which is not methylated
at the N7 position) were used as substrates, 3H-methyl groups
could not be incorporated either by GAV nsp16 or by SARS-CoV
nsp16/nsp10. In contrast, when RNA oligonucleotides containing
an N7-methylated cap-0 structure, 7MeGpppAC20 (black bars in
Fig. 2B), were used as substrates, efficient incorporation of 3H-
methyl groups by both GAV nsp16 and SARS-CoV nsp16/nsp10
was observed. These data suggest that GAV nsp16 can methylate
only the cap-0 structure of RNA substrates (7MeGpppA-RNA),
similarly to the coronavirus 2=-O-MTase.
It had been reported that vaccinia virus VP39 is a 2=-O-MTase
that modifies 5=-capped mRNA without any sequence specificity
FIG 1 Identification of nidovirus 2=-O-MTases. (A) Domain organization of the replicase pp1ab polyprotein for selected nidoviruses: SARS-CoV (coronavirus),
EToV (torovirus), and GAV (ronivirus). The predicted domains are indicated, and the predicted cleavage sites are marked with arrowheads. The domains are as
follows: ADP-ribose-1=-phosphatase (ADRP), papain-like proteinases (PLpro), chymotrypsin-like proteinase (3CLpro), RNA-dependent RNA polymerase
(RdRp), helicase (Hel), exonuclease (ExoN), N7-methyltransferase (N7MT), uridylate-specific endoribonuclease (Ne; also abbreviated NendoU), and 2=-O-
methyltransferase (2OMT). The coronavirus nsp10 and its similarly located counterparts in EToV and GAV are depicted in purple, and RFS stands for the
ribosomal frameshift site. The start sites and endpoints of the expressed proteins are indicated. (B) Expression and purification of recombinant viral proteins. The
gels of SDS-PAGE were stained with Coomassie brilliant blue. GAV nsp10, GAV nsp16, and EToV nsp16 are GST fusion proteins, and the others were 6-histidine
tagged. These protein bands are indicated with black arrows. (C) Activities of potential 2=-O-methyltransferases in 3H-methyl incorporation assays. Vaccinia
virus VP39 and SARS-CoV nsp10/nsp16 were used as positive controls, while SARS-CoV nsp10 acted as a negative control for 2=-O-MTase activity. The final
concentration of the nsp16 proteins of SARS-CoV, GAV, and EToV was 1 M. The cpm values reflect the 2=-O-MTase activity that was detected by liquid
scintillation counting. The error bars indicate standard deviations.
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(37). However, in our previous study, we found that SARS-CoV
nsp16 MTase methylated 7MeGpppA-RNA, but not 7MeGpppG-
RNA (5), indicating that SARS-CoV nsp16 is a sequence-depen-
dent 2=-O-methyltransferase acting on substrates starting with A.
In a similar way, we studied the substrate specificity of GAV
nsp16. A variety of capped RNA oligonucleotides (initiated with
different nucleotides followed by 20 cytidines, 7MeGpppAC20,
7MeGpppCC20,
7MeGpppUC20, and
7MeGpppGC20) and the cap
analog (7MeGpppA) were treated with purified GAV nsp16 in
the presence of 3H-labeled SAM, after which the products were
purified and measured by liquid scintillation counting. As
shown in Fig. 2C, GAV nsp16 had robust activity on the sub-
strate 7MeGpppAC20 but no detectable activity on
7MeGp-
ppUC20 and
7MeGpppGC20 (Fig. 2C). Of note, GAV nsp16
showed marginal activity on the substrate 7MeGpppCC20. These
results indicate that GAV nsp16 2=-O-MTase has a strong prefer-
ence for 7MeGpppA-initiated RNA, similar to SARS-CoV nsp10/
nsp16. Consistent with our observation, the very 5=-terminal nu-
cleotide of roniviruses is a conserved adenylate in all the genome
sequences that have been sequenced.
There was no activity of GAV nsp16 when the cap analog
7MeGpppA was used as the substrate (Fig. 2C), suggesting that the
length of the RNA substrate is relevant for GAV nsp16 2=-O-
MTase activity in vitro. We next investigated the correlation be-
tween MTase activity and RNA substrate length. RNA substrates
of different lengths (7MeGpppACn, where n ranges from 0 to 20)
were obtained as described in Materials and Methods and treated
with equal amounts of purified GAV nsp16. As shown in Fig. 2D,
there was no detectable 2=-O-MTase activity on RNA substrates
shorter than 5 nucleotides. There was marginal activity when the
RNA length reached 6 nucleotides (n  5), and the activity in-
creased gradually with the increase of RNA substrate length (n  5
to 8). The activity of GAV nsp16 reached a plateau when the RNA
length exceeded 9 nucleotides (n 	 8). These results imply that the
in vitro 2=-O-MTase activity of GAV nsp16 requires a certain
length of RNA substrate for full activity.
Biochemical parameters of GAV nsp16 activity. As the natu-
ral hosts for roniviruses are invertebrates, we further characterized
the biochemical parameters and optimal reaction conditions for
GAV nsp16 in vitro. First, the optimal temperature of the GAV
nsp16 methyltransferase reaction was determined. Since shrimps,
which are the natural hosts of GAV, live in environments with low
or variable temperatures, a temperature range from 10°C to 37°C
was tested. As shown in Fig. 3A, a typical bell-shaped distribution
FIG 2 RNA substrate specificity of GAV nsp16 2=-O-MTase. (A) (Lane 1) An RNA representing the first 68 nucleotides of the GAV genome was capped to form
7MeG*pppA-RNA, incubated with GAV nsp16, digested by nuclease P1 to release cap structures, and analyzed by TLC. (Lanes 2 to 4) Cap analogs used as controls
were generated by vaccinia virus capping enzymes D1/D12 in the absence of SAM (lane 2), in the presence of SAM (lane 3), and with SAM and VP39 2=-O-MTase
(lane 4). (B) SAM-dependent methyltransferase activities of GAV nsp16 and SARS nsp16. Equal amounts of proteins were incubated with AC20 (white),
GpppAC20 (gray), and
7MeGpppAC20 (black) in the presence of
3H-labeled SAM for 1 h, and radioactivity incorporation was detected by liquid





7MeGpppA were used as substrates to test GAV nsp16 activity. (D) GAV nsp16 2=-O-MTase activities on capped RNA substrates of
different lengths. The activity was formulated as a percentage (100% corresponds to the activity of 7MeGpppAC20). The error bars indicate standard deviations.
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was obtained, with optimal activity at 20°C, indicating that the
GAV enzyme is more active at a temperature that corresponds to
the natural ambient temperature of its host. In contrast, the 2=-O-
MTases of coronaviruses that infect mammalian hosts adopt a
higher temperature for optimal enzymatic activity (5).
We next tested the influence of pH on GAV nsp16 activity. pH
values between 6.0 and 11.0 were used, and this activity profile also
fit a bell-shaped distribution similar to that obtained when testing
the influence of the reaction temperature (Fig. 3B). The GAV 2=-
O-MTase had optimal activity at pH 8.0.
We also investigated the effect of divalent ions on GAV nsp16
at the optimal temperature and pH, since it has been reported that
divalent ions can stimulate the methyltransferase activities of sev-
eral 2=-O-MTases (20, 38). Mn2
, Mg2
, and Zn2
 were tested in
our assay. Surprisingly, none of these divalent ions could stimu-
late the activity of GAV nsp16. On the contrary, higher concen-
trations of Mg2
 even markedly suppressed the activity of GAV
nsp16 (Fig. 3C). We also determined the influence of Na
 on GAV
nsp16, as some 2=-O-MTases can tolerate only very low Na
 con-
centrations (39). Interestingly, GAV nsp16 was not inhibited by a
concentration of Na
 as high as 20 mM, which is different from
dengue virus NS5MTaseDV 2=-O-MTase (39) and vaccinia virus
VP39 (40).
The conserved K-D-K-E catalytic tetrad of the GAV 2=-O-
MTase is required for activity. The group of 2=-O-methyltrans-
ferases contains a conserved K-D-K-E catalytic tetrad, which is
vital for RNA 2=-O-MTase activity (20, 41, 42). To identify the
K-D-K-E catalytic tetrad of GAV nsp16, we made a comparative
analysis of GAV nsp16 with coronavirus nsp16. The multiple-
sequence alignment is shown in Fig. 4A. For SARS-CoV, the con-
served K-D-K-E residues of nsp16 were first predicted (Lys-46,
Asp-130, Lys-170, and Glu-203) and were subsequently con-
firmed by crystal structure analysis (5, 22). The amino acids
marked with asterisks in Fig. 4A constitute the predicted K-D-K-E
tetrad of GAV nsp16 (Lys-39, Asp-114, Lys-144, and Glu-178),
which are completely conserved in the 2=-O-methyltransferases of
nidoviruses. We next generated a structural model of GAV nsp16
(Fig. 4B) by homology-based modeling, using SARS-CoV nsp16
as the template (Fig. 4C). As shown in the schematic diagrams of
their structural topologies (Fig. 4D), GAV nsp16 and SARS-CoV
nsp16 share similar global structures, with a parallel array of
-strands surrounded by a number of -helices and loops. The
residues of the predicted K-D-K-E tetrad in GAV nsp16 are lo-
cated in an -helix with three parallel -strands, whose positions
are similar to those in SARS-CoV nsp16. However, the structural
model predicts that GAV nsp16 possesses a six-stranded -sheet
instead of the seven-stranded -sheet of many known 2=-O-meth-
yltransferases (5, 43). The missing -strand of GAV nsp16 would
correspond to -strand 3 (3) of SARS-CoV nsp16 (Fig. 4A and
D), but clearly, this structural difference first needs to be con-
firmed by future direct analysis of the structure of GAV nsp16.
To experimentally confirm the importance of the K-D-K-E
catalytic tetrad of GAV nsp16, the four residues (K39, D114, K144,
and E178) were mutated to either alanine or an amino acid residue
with similar chemical properties (R for K, E for D, and D for E). In
3H-methyl incorporation MTase activity assays, we found that the
wild-type enzyme possessed about 50% of the activity of SARS-
CoV nsp10/nsp16 (the positive control) when tested under their
respective optimal conditions (Fig. 5A and B). When any of the
four GAV residues was mutated to alanine, the 2=-O-MTase activ-
ity was completely abolished (Fig. 5A and B). When more conser-
vative substitutions were made, GAV nsp16 2=-O-MTase activity
was largely disrupted, but a trace amount of activity could be
observed (Fig. 5A and B). This indicates that both the charges and
the steric properties of the tetrad residues of GAV nsp16 influence
its MTase activity. For these assays, two RNA substrates, the
capped 5=-terminal 68 nt of the GAV genome (7MeGppp-5=UTR)
FIG 3 Determining the optimal reaction conditions for GAV nsp16. The GAV
nsp16 activity was measured in the presence of 3H-labeled SAM by liquid
scintillation counting of transferred 3H-methyl. (A) Effect of temperature on
enzymatic activity. Reactions were performed in Tris buffer (pH 8.0) with
incubation at various temperatures. RNAs were purified with Sephadex A-50
and detected by liquid scintillation counting. (B) Enzymatic activities of GAV
nsp16 at different pH values, including citric acid-NaOH (pH 6.0), Tris-HCl
buffer (pH 7.0 to 9.0), and Na2CO3-NaOH buffer (pH 10 and 11). An activity
of 100% corresponds to that at pH 8.0. (C) Influence of positive-valence metal
ions on enzymatic activity. The reactions were conducted at pH 8.0 and 20°C.
The error bars indicate standard deviations.
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FIG 4 Sequence alignment and homology modeling of GAV nsp16. (A) Multiple-sequence alignment of selected 2=-O-methyltransferases of nidoviruses. The -strands
of the canonical MTase fold are labeled from 1 to 7, and additional -strands from B1 onward. (B) Ribbon representation of the GAV nsp16 model structure,
generated based on the template structure of SARS nsp10/nsp16 (PDB accession no. 3R24). (C) SAM was added to the GAV nsp16 model by superimposition of the
model and the structure of SARS nsp10/nsp16 (PDB accession no. 3R24). The -strands were marked in accordance with the alignment. (D) Schematic diagrams of the
topologies of GAV nsp16 (modeled structure) and SARS nsp16. (E) Surface electrostatic potentials of GAV nsp16 (model) and SARS nsp16. The surface electrostatic
potential diagram was generated by PyMol; the blue areas represent positively charged areas, while the red areas represent negatively charged areas.
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(Fig. 5A) and the capped oligonucleotide 7MeGpppAC20 (Fig. 5B),
were tested, and the results were consistent.
The 2=-O-MTase activities of GAV nsp16 mutants were also
tested by nuclease P1 treatment and TLC assays. As shown in
Fig. 5C, all the GAV nsp16 mutants were crippled in their 2=-O-
MTase activities, which was in accordance with the results of the
3H-methyl-labeled assays (Fig. 5A and B).
Taking the data together, we concluded that residues Lys-39,
Asp-114, Lys-144, and Glu-178 of GAV nsp16 likely constitute the
K-D-K-E catalytic tetrad that is essential for 2=-O-MTase activity.
Effects of MTase inhibitors on GAV nsp16 2=-O-MTase activ-
ity. To further characterize the enzymatic activity of GAV nsp16,
we tested whether the activity could be inhibited by previously
characterized MTase inhibitors, such as S-(5=-adenosyl)-L-homo-
cysteine (SAH, or AdoHcy), sinefungin, and ribavirin. SAH is a
by-product of the SAM-dependent methyl transfer reaction. Sine-
fungin is a SAM analog, and ribavirin is a GTP analog. These three
small molecules have often been used to inhibit SAM-dependent
methyltransferases (39, 44, 45). As shown in Fig. 6, sinefungin and
AdoHcy were the most efficient inhibitors, and their half-maximal
inhibitory concentrations (IC50) were determined to be 28.7 and
73.9 M, respectively (Fig. 6A and C). Ribavirin was much less
efficient in our GAV nsp16 assay (Fig. 6B). Compared with the
values reported for other viral 2=-O-MTases, we found that these
three compounds had varying effects on different MTases. For
examples, the IC50 of AdoHcy is 0.34 M for the 2=-O-MTase of
dengue virus NS5MTaseDV (39) and 144 M for FCoV nsp16
(20). Ribavirin did not exert a significant inhibitory effect on 2=-
O-MTase of dengue virus NS5MTaseDV (39), similar to our ob-
servations with GAV nsp16.
DISCUSSION
Nidoviruses have linear, single-stranded RNA genomes with pos-
itive polarity that contain a 5= cap structure and a 3= poly(A) tail
(17). Several enzymes are involved in the formation of the 5= cap
structure of viral RNA and host mRNA, including RNA triphos-
phatase, guanylyltransferase, N7-MTase, and 2=-O-MTase (1, 2,
4). In coronaviruses, the N7- and 2=-O-MTases have been studied
in the most detail, and the two enzymes were found to play im-
portant roles in the modification of the viral cap structure (5, 18,
22), while the RNA helicase nsp13 of coronaviruses could func-
tion as an RNA triphosphatase (46). Until now, the guanylyltrans-
ferase of coronaviruses has been completely unknown. However,
no experimental evidence for the activities of these enzymes is
available for any of the other nidoviruses, and in the case of arteri-
viruses, it has even become quite uncertain whether the viral rep-
licase includes any MTases at all (47). Although bioinformatics
analyses have predicted that roniviruses and toroviruses, like
coronaviruses, encode a methyltransferase near the 3= end of
ORF1b (17, 34, 48), they were not confirmed experimentally. In
this study, we expressed and purified the putative methyltrans-
ferases of EToV (torovirus) and GAV (ronivirus) according to the
bioinformatics-based prediction of the natural replicase cleavage
sites (30, 36), and we provided experimental evidence that GAV
nsp16 indeed possesses 2=-O-MTase activity. Surprisingly, the to-
rovirus nsp16, which is more closely related to coronavirus nsp16,
did not show any 2=-O-MTase activity in our assays. The failure to
detect 2=-O-MTase activity for torovirus nsp16 may reflect its in-
trinsic properties or the limitations of our assay. For example,
torovirus nsp16 may require an additional protein cofactor other
than the nsp10 used by coronaviruses or other RNA substrate
requirements than those used here.
Our results indicate that, like the coronaviral 2=-O-MTase,
GAV nsp16 can discriminate an N7-methylated RNA cap from a
nonmethylated cap (20). This is different from other viral 2=-O-
FIG 5 Activities of wild-type (WT) GAV nsp16 and K-D-K-E mutants. (A)
MTase activities of GAV nsp16 (WT and mutants) detected by using 7MeG-
pppAC20 as the substrate in
3H-methyl incorporation assays. (B) MTase activ-
ities of GAV nsp16 (WT and mutants) detected by using 7MeGppp-RNA (GAV
5=UTR) as the substrate in 3H-methyl incorporation assays. (C) MTase activ-
ities of GAV nsp16 (WT and mutants) analyzed by RNA digestion and TLC
assays. Lane 4 represents the WT of GAV nsp16; lane 2 is a negative control,
lane 3 is a positive control treated with vaccinia virus VP39, and lanes 5 to 12
are mutants of GAV nsp16. The error bars indicate standard deviations.
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MTases, such as those of dengue virus and Meaban virus, which
are able to transfer methyl groups from AdoMet to both methyl-
ated and unmethylated RNA caps (GpppACn and
7MeGpppACn)
at the 2=-O position of the first nucleotide (20, 39, 49, 50). GAV
nsp16 can efficiently methylate only RNA substrates with a
5=-terminal A, similar to SARS-CoV nsp16, while vaccinia virus
VP39 is a 2=-O-MTase that works in a sequence-nonspecific man-
ner (37). This indicates that GAV nsp16 is a more specific cap-
modifying enzyme in the recognition of 5=-capped viral RNA.
Interestingly, unlike coronavirus nsp16, in vitro, GAV nsp16
can function alone in the absence of any other viral protein, sug-
gesting that in vivo, it also may not require a protein cofactor to
stimulate its enzymatic activity. As shown in our previous work,
SARS-CoV nsp10, the cofactor of the nsp16 2=-O-MTase, acts as a
buttress to support the pocket involved in SAM binding and thus
enhances the binding affinity for SAM (5).
The 3D structure model predicts that GAV nsp16 will have
some remarkable difference from SARS-CoV nsp16. First, the
SAM-binding pocket of GAV nsp16 appears to have a more rigid
structure and may be stable enough to bind with the methyl donor
SAM. In contrast, the SAM-binding pocket of SARS-CoV nsp16
possesses a flexible loop (residues 100 to 108) (Fig. 4). Second, the
equivalent of the 3-strand of SARS-CoV nsp16 is predicted to be
missing in GAV nsp16. Third, the analysis of the electrostatic po-
tential shows that the RNA-binding groove on the surface of GAV
nsp16 is longer than that of SARS nsp16 (Fig. 4E); the former is
about 32 Å in length and fits well with the requirement for a 6-nt
RNA substrate (7MeGpppAC5), which is consistent with our ob-
servation that the shortest RNA substrate on which GAV nsp16
showed 2=-O-MTase activity was 6 nt long (Fig. 2D). This obser-
vation may in part explain why GAV does not need a viral protein
cofactor for its enzymatic activity, whereas SARS-CoV nsp16 re-
quires nsp10 to extend its RNA-binding groove to accommodate
its RNA substrate efficiently, as demonstrated in our previous
study (5). These structural differences may contribute to the dis-
tinct properties of coronavirus and ronivirus 2=-O-MTases and
thus may explain why ronivirus nsp16 does not need a protein
cofactor for MTase activity.
Through sequence alignment and mutational analysis, we
identified the conserved K-D-K-E catalytic tetrad of GAV nsp16,
which is similar to that of the typical RNA cap-1 structure-modi-
fying enzymes. The catalytic tetrad is K39-D114-K144-E178 (Fig. 4A).
Homology modeling showed that GAV nsp16 has a six-stranded
-sheet arrayed in parallel in the middle of the protein sur-
rounded by -helices and loops, while the -sheet is seven
stranded in SARS-CoV nsp16 and many other known 2=-O-meth-
yltransferases (5, 43). Nevertheless, the six-stranded -sheet is
also reported for some other MTases, e.g., the RNA methyltrans-
ferase TlyA (51), which is missing the third -strand located at the
edge of the seven-stranded -sheet structure. The four amino acid
residues in the GAV nsp16 catalytic tetrad K39-D114-K144-E178 of
GAV nsp16 are located at positions similar to those of the tetrad
K46-D130-K170-E203 of SARS-CoV nsp16.
It is well-known that the cap structure is very important for
mRNA stability and translation. It has been demonstrated that
2=-O methylation of viral RNA caps is also important for RNA
viruses to evade host innate immune recognition (7, 8, 52). There-
fore, viral capping enzymes are potential targets for antiviral drug
development. Recently, we demonstrated that a coronavirus
nsp10-derived short peptide can potently inhibit nsp16 2=-O-
MTase activity in vitro and viral replication in animals (15). In the
future, such small-molecule inhibitors can be developed to target
the 2=-O-MTases of other nidoviruses that infect humans and
mammals. In this study, we showed that the well-known MTase
inhibitor sinefungin possesses inhibitory activity on GAV nsp16.
Although it appears unlikely to produce efficient and cost-effec-
tive antiviral drugs against shrimp viruses, debilitation of GAV
2=-O-MTase may be used as a strategy to generate live attenuated
FIG 6 Inhibition of GAV nsp16 2=-O-MTase activity by established methyl-
transferase inhibitors. Increasing concentrations of sinefungin (A), ribavirin
(B), and AdoHcy (a by-product of the reaction) (C) were added to the reaction
mixtures, and the activity was measured by using 3H-methyl incorporation
MTase activity assays. The error bars indicate standard deviations.
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ronivirus vaccines, like that used to produce coronavirus and fla-
vivirus vaccines (9–12).
In summary, we have identified and characterized the 2=-O-
methyltransferase of GAV, extending our knowledge of RNA cap
formation and methylation beyond coronaviruses in the order
Nidovirales. The ronivirus 2=-O-MTase shows both similarities
and unique features compared with the coronavirus 2=-O-MTase.
The K-D-K-E catalytic tetrad of GAV nsp16 is well conserved, but
ronivirus 2=-O-MTase does not require a protein cofactor to stim-
ulate its activity and possibly possesses a six-stranded -sheet in-
stead of a canonical seven-stranded -sheet in the core of the
MTase structure.
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